|
ZNF670 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.6242562850266E-12 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
6.3726801613484E-14 |
| Normal-vs-Stage2 |
5.27520027659989E-10 |
| Normal-vs-Stage3 |
1.3319345626428E-12 |
| Normal-vs-Stage4 |
2.50210963059772E-12 |
| Stage1-vs-Stage2 |
4.500800E-01 |
| Stage1-vs-Stage3 |
4.137000E-01 |
| Stage1-vs-Stage4 |
3.711700E-02 |
| Stage2-vs-Stage3 |
8.910400E-01 |
| Stage2-vs-Stage4 |
2.537200E-01 |
| Stage3-vs-Stage4 |
1.683380E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
3.33066907387547E-16 |
| Normal-vs-AfricanAmerican |
1.9715099999984E-05 |
| Normal-vs-Asian |
2.24480000032834E-07 |
| Caucasian-vs-AfricanAmerican |
8.147600E-01 |
| Caucasian-vs-Asian |
4.383800E-01 |
| AfricanAmerican-vs-Asian |
7.817600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
8.99280649946377E-15 |
| Normal-vs-Female |
1.62525548574877E-12 |
| Male-vs-Female |
4.170400E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
6.91902091176644E-12 |
| Normal-vs-Age(41-60Yrs) |
6.66133814775094E-15 |
| Normal-vs-Age(61-80Yrs) |
1.63913327355658E-12 |
| Normal-vs-Age(81-100Yrs) |
2.644300E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.703000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
9.104300E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
9.579200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
4.375600E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
6.792200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
4.519400E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
1.652390E-01 |
| Classical-VS-Follicular |
9.520900E-03 |
| Classical-VS-Other |
1.406390E-01 |
| Classical-VS-Normal |
1.65323310596932E-12 |
| Tall-VS-Follicular |
7.321400E-01 |
| Tall-VS-Other |
4.499800E-01 |
| Tall-VS-Normal |
1.65850000399814E-09 |
| Follicular-VS-Other |
6.146600E-01 |
| Follicular-VS-Normal |
3.09141601206875E-12 |
| Other-VS-Normal |
3.015500E-04 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
3.33066907387547E-16 |
| Normal-vs-N1 |
1.20749965581979E-10 |
| N0-vs-N1 |
5.041400E-01 |
|
|
